Nevro (NVRO) Misses Q2 EPS by 10c, Sales Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. INSP
9. HNGE
10. SPY

Go back to Nevro (NVRO) Misses Q2 EPS by 10c, Sales Beat

Nevro Reports Second Quarter 2017 Financial Results

August 7, 2017 4:14 PM EDT

REDWOOD CITY, Calif., Aug. 7, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today reported financial results for the three and six months ended June 30, 2017.

Second Quarter Highlights:

Achieved revenue of $78.0 million in the second quarter of 2017, an increase of 41% as reported, over the same period of the prior year U.S. revenue of $63.0 million in the second quarter of 2017, an increase of 55% over the prior year... More